Related Experiment Videos

A highly efficient gene delivery system derived from feline immunodeficiency virus (FIV)

Sybille L Sauter¹, Mehdi Gasmi, Thomas W Dubensky

¹GenStar Therapeutics Inc., San Diego, CA, USA.

Methods in Molecular Medicine

|January 16, 2003

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

First-in-human Phase I Trial of TPST-1120, an Inhibitor of PPARα, as Monotherapy or in Combination with Nivolumab, in Patients with Advanced Solid Tumors.

Cancer research communications·2024

Dual Blockade of EP2 and EP4 Signaling is Required for Optimal Immune Activation and Antitumor Activity Against Prostaglandin-Expressing Tumors.

Cancer research communications·2023

Comprehensive Preclinical Assessment of ADVM-022, an Intravitreal Anti-VEGF Gene Therapy for the Treatment of Neovascular AMD and Diabetic Macular Edema.

Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics·2021

Long-Term Safety Evaluation of Continuous Intraocular Delivery of Aflibercept by the Intravitreal Gene Therapy Candidate ADVM-022 in Nonhuman Primates.

Translational vision science & technology·2021

Analysis of Aflibercept Expression in NHPs following Intravitreal Administration of ADVM-022, a Potential Gene Therapy for nAMD.

Molecular therapy. Methods & clinical development·2020

Structure comparison of the chimeric AAV2.7m8 vector with parental AAV2.

Journal of structural biology·2019

See all related articles